Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.

Trace Neuroscience

Eric Green

This department focuses on scientific research and innovations to advance product development.

Research and Development

This department focuses on strategic growth initiatives, mergers, acquisitions, and financial management.

Corporate Development

This department focuses on overseeing operational efficiency and strategic initiatives across the organization.

Trace Neuroscience

Org chart

Teams

Research and Development

Corporate Development

Operations and Strategy

Offices

Trace Neuroscience

Org chart

Teams

Research and Development

Corporate Development

Operations and Strategy

Offices

Related companies